The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA

scientific article published on 01 November 1999

The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10545066

P2093author name stringA Magklara
A Scorilas
E P Diamandis
W J Catalona
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectprostatic hypertrophyQ506659
P304page(s)1960-1966
P577publication date1999-11-01
P1433published inClinical ChemistryQ849687
P1476titleThe combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
P478volume45

Reverse relations

cites work (P2860)
Q42134811A pilot study on percent free prostate specific antigen as an additional tool in prostate cancer screening.
Q80295712Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer
Q36424700Carbonic anhydrase I as a new plasma biomarker for prostate cancer.
Q28360883Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer
Q33922390Current early diagnostic biomarkers of prostate cancer
Q40788240Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
Q28344337Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
Q24642830Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer
Q36936018Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.
Q35783032Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer
Q24646799Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
Q37338478Screening for prostate cancer: an update.
Q34707859The role of free prostate-specific antigen in prostate cancer detection
Q79077769[Serum markers for early detection and staging of prostate cancer. Status report on current and future markers]

Search more.